Overcoming the need for a cold chain with conjugated meningococcal Group C vaccine: A controlled, randomized, double-blind study in toddlers on the safety and immunogenicity of Menjugate®, stored at room temperature for 6 months

This publication has 30 references indexed in Scilit:

• Revolutionary vaccine technology breaks the cold chain
  The Lancet Infectious Diseases, 2004
• Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis
  BMJ, 2003
• Dramatic decline of serogroup C meningococcal disease in Catalonia (Spain) after a mass vaccination campaign with meningococcal C conjugated vaccine
  Vaccine, 2003
• Can needle-free administration of vaccines become the norm in global immunization?
  Nature Medicine, 2003
• Impact of meningococcal C conjugate vaccine in the UK
  Journal of Medical Microbiology, 2002
• Physico-chemical and immunological examination of the thermal stability of tetanus toxoid conjugate vaccines
  Vaccine, 2002
• Frequency and causes of vaccine wastage
  Vaccine, 2001
• Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6–8 October, 2000
  Vaccine, 2001
• Assessment of the stability and immunogenicity of meningococcal oligosaccharide C-CRM197 conjugate vaccines
  Vaccine, 2000
• A Trial Of A Group A Plus Group C Meningococcal Polysaccharide-Protein
  The Journal of Infectious Diseases, 1995